Tag: Survival
Tusamitamab Ravtansine Does Not Extend Survival With Nonsquamous NSCLC
Findings seen in patients previously treated with platinum-based chemotherapy and immunotherapy whose tumors highly expressed CEACAM5
Perioperative Nivolumab Beneficial for Resectable NSCLC
Perioperative nivolumab showed event-free survival benefit from time of surgery compared with neoadjuvant nivolumab
Stroke Survivors More Likely to Have Abnormal Sleep Duration
Stroke survivors more likely to report more than eight hours, less than seven hours, and less than six hours/night
Caseload Strain Linked to Patient Survival During Delta Wave of COVID-19
One in five COVID-19 deaths due to strain-attributable mortality; findings were consistent across hospital types
Half of Cancer Survivors Face Cancer-Related Financial Hardship
Higher hardship seen with younger age, Medicare beneficiaries, social vulnerability and advanced disease
Mediterranean Diet Adherence Tied to Lower Mortality for Cancer Survivors
Each 2-point increase in Mediterranean diet score linked to significantly lower all-cause mortality
Hospital Nursing Resources Tied to COVID-19 Survival
Findings for both in-hospital death and 30-day postdischarge mortality
Burden of Chronic Health Conditions Increased for LGTBQ+ Cancer Survivors
Highest prevalence of all outcomes seen among transgender or gender-nonconforming survivors
Survival Benefit for Cancer Trial Participants Does Not Persist in Adjusted Analyses
Survival benefits disappear when only high-quality studies are pooled and with adjustment for potential publication bias
Symptom Burden Prevalent in Childhood Cancer Survivors
Caregiver anxiety and neighborhood factors associated with greater symptom burden
